1. Home
  2. HOG vs SRPT Comparison

HOG vs SRPT Comparison

Compare HOG & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harley-Davidson Inc.

HOG

Harley-Davidson Inc.

HOLD

Current Price

$24.25

Market Cap

2.5B

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$17.64

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOG
SRPT
Founded
1903
1980
Country
United States
United States
Employees
6400
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.5B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
HOG
SRPT
Price
$24.25
$17.64
Analyst Decision
Hold
Hold
Analyst Count
7
29
Target Price
$24.00
$25.85
AVG Volume (30 Days)
2.7M
2.6M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
3.05%
N/A
EPS Growth
N/A
N/A
EPS
0.22
2.88
Revenue
$4,473,175,000.00
$2,198,237,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.79
N/A
P/E Ratio
$109.59
$5.99
Revenue Growth
N/A
15.58
52 Week Low
$17.09
$10.42
52 Week High
$31.25
$43.92

Technical Indicators

Market Signals
Indicator
HOG
SRPT
Relative Strength Index (RSI) 53.18 42.49
Support Level $22.36 $17.11
Resistance Level $24.83 $18.10
Average True Range (ATR) 0.96 0.77
MACD -0.19 -0.09
Stochastic Oscillator 40.09 28.85

Price Performance

Historical Comparison
HOG
SRPT

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: